Beginning from 1st October 2013, HLA-B*15:02 is accessible to majority of Thai citizen who is attending 53 hospitals in Bangkok supported by National Health Security Office (NHSO). The tests are available for the first 2,000 patients who initiated Carbamazepine and this is the preventive measure fot reducing the SJS/TENS in Bangkok. |
HLA-B*15:02 testing are available in Bangkok through support from NHSO
HLA-B*15:02 tests are pilot testing in Bangkok
Start from 1st October HLA-B*15:02 test are supported for all patients in Bangkok, Please contact dmscnetwork@thailandpg.org for more information |
| Attachments:
CSC_8387.JPG
14th June 2012; The progress monitoring meeting of ThaiSCAR
 In the meeting, we reported the results of analysis of first 29 cases of SJS/TENS enrolled from 5 hospitals in the first year of the study, the results were of most interested to the participants and we're looking forward for a detail analysis after we're getting more samples at the end of Thai fiscal year in September. We would like to also welcome new participants from the new members of the networks. Current members included 16 hospitals distributed all over Thailand, and the number is keep growing. This number will be updated annually in our website. |
19th May 2011 meeting for ThaiSCAR study
August meeting for utilization of pharmacogenomics in Thailand
A meeting will be held on 26th august 2010 for the discussion to implement the HLA-B tests for medical services providers in Thailand. A expert panel will be called from neurologists in Ministry of public health to discuss the utility of HLA-B*1502 to prevent Carbamazepine induced SJS/TENS in Thais. If the panels agrees in pursing the further research and/or services, we will form a formal collaboration among the participants and establish a formal conversation for utilization of pharmacogenomics in Thailand. The meeting venue will be at Miracle Grand Hotel, coincides with DMSc research meeting |
GAP-J 2010 meeting in Hawai'i
During 9-10 February 2010, Dr. Surakameth Mahasirimongkol was invited to attend the Global Alliance for Pharmacogenomics (GAP-J) meeting. The alliance shall expand this year to include France and Thailand as two new alliances. The meeting is very interesting for pharmacogenomics research. Various pharmacogenomics researches were presented at the meeting with results of genome-wide association analysis shown for various drugs/diseases. We are looking for new fruitful collaboration with our global colleagues. |
Queen Sirikit National Institute of Child Health
The meeting with Clinical Neurologist and Dermatologists in the Queen Sirikit National Institute of Child Health on 11/8/2009 was concluded that the following three activities shall be set up for the pharmacogenomics research collaboration between DMSc and the QSNICH. 1) Case-control study for association analysis of HLA-B*1502 in Thai Children who prescribed Carbamazepine. 2) Participating in the multi-center clinical research network for clinical investigation of SJS/TENS in Thailand. 3) Operational study for Prospective intervention using HLA-B*1502 status to prevent Carbamazepine induced SJS/TENS. |
Meeting with NHSO director
10/8/2009 A meeting with NHSO director to explore the possibility of PG test in Thailand |
1-8 of 8